- Home
- POLA vs LGVN Comparison
POLA vs LGVN Comparison
Compare POLA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- LGVN
- Stock Information
- Founded
- POLA 1979
- LGVN 2014
- Country
- POLA United States
- LGVN United States
- Employees
- POLA N/A
- LGVN N/A
- Industry
- POLA Industrial Machinery/Components
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- POLA Miscellaneous
- LGVN Health Care
- Exchange
- POLA Nasdaq
- LGVN Nasdaq
- Market Cap
- POLA 4.3M
- LGVN 23.4M
- IPO Year
- POLA 2016
- LGVN 2021
- Fundamental
- Price
- POLA $1.91
- LGVN $1.43
- Analyst Decision
- POLA
- LGVN Strong Buy
- Analyst Count
- POLA 0
- LGVN 3
- Target Price
- POLA N/A
- LGVN $8.67
- AVG Volume (30 Days)
- POLA 280.1K
- LGVN 711.7K
- Earning Date
- POLA 08-13-2025
- LGVN 08-13-2025
- Dividend Yield
- POLA N/A
- LGVN N/A
- EPS Growth
- POLA N/A
- LGVN N/A
- EPS
- POLA N/A
- LGVN N/A
- Revenue
- POLA $13,918,000.00
- LGVN $2,225,000.00
- Revenue This Year
- POLA N/A
- LGVN N/A
- Revenue Next Year
- POLA N/A
- LGVN $51.48
- P/E Ratio
- POLA N/A
- LGVN N/A
- Revenue Growth
- POLA 8.08
- LGVN 127.50
- 52 Week Low
- POLA $1.53
- LGVN $1.14
- 52 Week High
- POLA $4.69
- LGVN $4.94
- Technical
- Relative Strength Index (RSI)
- POLA 62.97
- LGVN 59.84
- Support Level
- POLA $1.82
- LGVN $1.27
- Resistance Level
- POLA $1.97
- LGVN $1.40
- Average True Range (ATR)
- POLA 0.16
- LGVN 0.11
- MACD
- POLA 0.03
- LGVN 0.04
- Stochastic Oscillator
- POLA 33.70
- LGVN 61.40
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.